According to Google DeepMind’s official blog, the company has released AlphaGenome Atlas, a free platform offering precomputed predictions for the molecular effects of all 9 billion possible single-nucleotide variants in the human genome.
Built on DeepMind’s AlphaGenome model, the Atlas also introduces the AVI (AlphaGenome Variant Impact) score, a single ranking number combining AlphaGenome and AlphaMissense predictions, covering both coding and non-coding regions of the genome.
DeepMind says early academic collaborators have already used the Atlas to identify disease-linked variants in rare disease and population genetics research. The company describes the release as a “baseline rather than an endpoint,” with further model improvements expected.
The Atlas is available now via a web portal and API for academic use, with commercial access on Google Cloud “soon.”
This is a preliminary summary based on DeepMind’s announcement. A detailed analysis with expert commentary will be published shortly.
Updated: Sept 9, 2026, 10:35 PM IST
Sources: Reference Paper | Reference Article
Disclaimer:
The research discussed in this article was conducted and published by the authors of the referenced paper. CBIRT has no involvement in the research itself. This article is intended solely to raise awareness about recent developments and does not claim authorship or endorsement of the research.
Important Note: This blog is based on a company announcement and a preprints that have not yet undergone peer review. As a result, it is important to note that these papers should not be considered conclusive evidence, nor should they be used to direct clinical practice or influence health-related behavior. It is also important to understand that the information presented in these papers is not yet considered established or confirmed.
Follow Us!
Learn More:
